You have two patients in adjacent beds in the medical ward. One had suffered a STEMI five days ago and the other had suffered a NSTEMI three days ago. Both are stable at the moment.


1. Which of these patients is likely to be at increased risk of death in the next 30 days?

2. Why is thrombolytic therapy with Streptokinase offered only to those with STEMI?

3. What is the difference in the infarct-related coronary arteries in both these patients?

Unless otherwise stated, the content of this page is licensed under Creative Commons Attribution-ShareAlike 3.0 License